RadComp Newsletter - July 2022 |
|
|
|
Partner in Patient Advocacy - LatinaSHARE |
LatinaSHARE, RadComp's newest advocacy partner, has supported, educated, and brought awareness to underserved communities for 28 years. Jennie Santiago, Senior Director of LatinaSHARE Patient Support & Education, shares her commitment to supporting the Latina community.
|
|
|
|
How RadComp Uses & Protects Social Security Numbers |
RadComp seeks to learn about participants' long-term health after radiation. To achieve this, we gather personal information from participants. Read on to review the purpose, use, and protection of participants' social security numbers.
|
|
|
|
Please Update Your Contact Information |
Has your address, phone number, or email changed in the past year? If so, please contact us. Keeping your contact information up-to-date will allow us to better reach you with news and updates, such as study results.
If you have already contacted us - thank you!
|
|
|
|
Attention Study Participants: We Want to Hear From You! |
|
Would you be interested in a private, moderated Facebook Group just for RadComp participants?
|
|
|
|
Advocacy Partner Events & Resources |
|
|
|
Share your Experience on the Cancer Experience Registry
The Cancer Support Community's Cancer Experience Registry (CER) survey uncovers the impacts of cancer so patients and caregivers receive the support they need. By taking the survey, you would help influence health policy, enhance cancer care, & improve support services.
|
|
|
|
Living Well: Optimizing Your Nutrition & Detoxifying Your Kitchen |
Living Beyond Breast Cancer is hosting a two-part webinar series on July 26 & August 2. During the program, experts Rachel Beller, MS, RDN, and Olga Naidenko, PhD, will share practical and accessible ways to optimize your diet and reduce toxicity in your kitchen that you can incorporate into your daily life right away.
|
|
|
|
Evaluation and Management of Insomnia in Women With Breast Cancer
Authors: Kwak, A., Jacobs, J., Haggett, D. et al.
Journal: Breast Cancer Res Treat, 181, 269–277 (2020).
|
|
Study Participant Enrollment |
|
|
|
As of June 30, 2022, 1,113 participants have joined the RadComp Trial, 10 in June.
We are 87% of the way to complete enrollment of 1,278 participants! Together, we are powering the future of breast cancer treatment.
|
|
|
|
This newsletter was funded through a Patient-Centered Outcomes Research Institute (PCORI) Award (PCS-1403-12804). The views, statements, and opinions presented are solely the responsibility of the author(s) and do not necessarily represent the views of the Patient-Centered Outcomes Research Institute (PCORI), its Board of Governors or Methodology Committee. |
|
|
|
|
|
|
